Androgen Receptor CAG Repeat Length and TMPRSS2:ETS Prostate Cancer Risk: Results From the Prostate Cancer Prevention TrialFIGG, William D; CHAU, Cindy H; VAN BOKHOVEN, Adrie et al.Urology (Ridgewood, NJ). 2014, Vol 84, Num 1, pp 127-131, issn 0090-4295, 5 p.Article

Plasma Vitamin D and Prostate Cancer Risk: Results from the Selenium and Vitamin E Cancer Prevention TrialKRISTAL, Alan R; TILL, Cathee; MINASIAN, Lori M et al.Cancer epidemiology, biomarkers & prevention. 2014, Vol 23, Num 8, pp 1494-1504, issn 1055-9965, 11 p.Article

Serum 25-Hydroxyvitamin D Concentrations and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention TrialSCHENK, Jeannette M; TILL, Cathee A; TANGEN, Catherine M et al.Cancer epidemiology, biomarkers & prevention. 2014, Vol 23, Num 8, pp 1484-1493, issn 1055-9965, 10 p.Article

Human Papillomavirus Types 16, 18, and 31 Serostatus and Prostate Cancer Risk in the Prostate Cancer Prevention TrialSUTCLIFFE, Siobhan; VISCIDI, Raphael P; TILL, Cathee et al.Cancer epidemiology, biomarkers & prevention. 2010, Vol 19, Num 2, pp 614-618, issn 1055-9965, 5 p.Article

Select : The next prostate cancer prevention trialKLEIN, Eric A; THOMPSON, Ian M; LIPPMAN, Scott M et al.The Journal of urology. 2001, Vol 166, Num 4, pp 1311-1315, issn 0022-5347Conference Paper

Chronic Inflammation in Benign Prostate Tissue Is Associated with High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention TrialGUREL, Bora; LUCIA, M. Scott; PESKOE, Sarah B et al.Cancer epidemiology, biomarkers & prevention. 2014, Vol 23, Num 5, pp 847-856, issn 1055-9965, 10 p.Article

Long-Term Survival of Participants in the Prostate Cancer Prevention TrialTHOMPSON, Ian M; GOODMAN, Phyllis J; TANGEN, Catherine M et al.The New England journal of medicine. 2013, Vol 369, Num 7, pp 603-610, issn 0028-4793, 8 p.Article

Chemoprevention of Prostate Cancer. CommentaryTHOMPSON, Ian M; TANGEN, Catherine M; GOODMAN, Phyllis J et al.The Journal of urology. 2009, Vol 182, Num 2, pp 499-508, issn 0022-5347, 10 p.Article

Men with Low Serum Cholesterol Have a Lower Risk of High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention TrialPLATZ, Elizabeth A; TILL, Cathee; GOODMAN, Phyllis J et al.Cancer epidemiology, biomarkers & prevention. 2009, Vol 18, Num 11, pp 2807-2813, issn 1055-9965, 7 p.Article

Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increaseKRISTAL, Alan R; CHEN CHI; TANGEN, Catherine M et al.Cancer. 2006, Vol 106, Num 2, pp 320-328, issn 0008-543X, 9 p.Article

Estimated impact of the prostate cancer prevention trial on population mortalityUNGER, Joseph M; THOMPSON, Ian M; LEBLANC, Michael et al.Cancer. 2005, Vol 103, Num 7, pp 1375-1380, issn 0008-543X, 6 p.Article

Factors Associated with Adherence to an End-of-Study Biopsy: Lessons from the Prostate Cancer Prevention Trial (SWOG-Coordinated Intergroup Study S9217)GRITZ, Ellen R; ARNOLD, Kathryn B; SZCZEPANEK, Connie et al.Cancer epidemiology, biomarkers & prevention. 2014, Vol 23, Num 8, pp 1638-1648, issn 1055-9965, 11 p.Article

Insulin-Like Growth Factors and Insulin-Like Growth Factor― Binding Proteins and Prostate Cancer Risk: Results from the Prostate Cancer Prevention TrialNEUHOUSER, Marian L; PLATZ, Elizabeth A; HOQUE, Ashraful et al.Cancer prevention research (Philadelphia, Pa.). 2013, Vol 6, Num 2, pp 91-99, issn 1940-6207, 9 p.Article

Predicting Risk of Prostate Cancer in Men Receiving Finasteride: Effect of Prostate Volume, Number of Biopsy Cores, and American Urological Association Symptom ScoreANKERST, Donna P; TILL, Cathee; BOECK, Andreas et al.Urology (Ridgewood, NJ). 2013, Vol 82, Num 5, pp 1076-1081, issn 0090-4295, 6 p.Article

The Prostate Cancer Prevention Trial Risk Calculator and the Relationship Between Prostate-Specific Antigen and Biopsy OutcomeVICKERS, Andrew J; SJOBERG, Daniel D; ANKERST, Donna P et al.Cancer. 2013, Vol 119, Num 16, pp 3007-3011, issn 0008-543X, 5 p.Article

Evaluation of Vitamin E and Selenium Supplementation for the Prevention of Bladder Cancer in SWOG Coordinated SELECTLOTAN, Yair; GOODMAN, Phyllis J; YOUSSEF, Ramy F et al.The Journal of urology. 2012, Vol 187, Num 6, pp 2005-2010, issn 0022-5347, 6 p.Article

Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)KLEIN, Eric A; THOMPSON, Ian M; KARP, Daniel D et al.JAMA, the journal of the American Medical Association. 2011, Vol 306, Num 14, pp 1549-1556, issn 0098-7484, 8 p.Article

Assessing prostate cancer risk : Results from the prostate cancer prevention trialTHOMPSON, Ian M; ANKERST, Donna Pauler; CHEN CHI et al.Journal of the National Cancer Institute. 2006, Vol 98, Num 8, pp 529-534, issn 0027-8874, 6 p.Article

Effect of finasteride on the sensitivity of PSA for detecting prostate cancerTHOMPSON, Ian M; CHEN CHI; ANKERST, Donna Pauler et al.Journal of the National Cancer Institute. 2006, Vol 98, Num 16, pp 1128-1133, issn 0027-8874, 6 p.Article

Erectile dysfunction and subsequent cardiovascular diseaseTHOMPSON, Ian M; TANGEN, Catherine M; GOODMAN, Phyllis J et al.JAMA, the journal of the American Medical Association. 2005, Vol 294, Num 23, pp 2996-3002, issn 0098-7484, 7 p.Article

Baseline Selenium Status and Effects of Selenium and Vitamin E Supplementation on Prostate Cancer RiskKRISTAL, Alan R; DARKE, Amy K; LIPPMAN, Scott M et al.Journal of the National Cancer Institute. 2014, Vol 106, Num 3, issn 0027-8874, 1.1-1.8Article

Statin Drug Use is Not Associated with Prostate Cancer Risk in Men Who are Regularly ScreenedPLATZ, Elizabeth A; TANGEN, Catherine M; THOMPSON, Ian M et al.The Journal of urology. 2014, Vol 192, Num 2, pp 379-384, issn 0022-5347, 6 p.Article

Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection. CommentaryTHOMPSON, Ian M; TANGEN, Catherine M; GOODMAN, Phyllis J et al.The Journal of urology. 2007, Vol 177, Num 5, pp 1749-1752, issn 0022-5347, 4 p.Article

Prediction of prostate cancer for patients receiving finasteride : Results from the prostate cancer prevention trialTHOMPSON, Ian M; ANKERST, Donna Pauler; CHEN CHI et al.Journal of clinical oncology. 2007, Vol 25, Num 21, pp 3076-3081, issn 0732-183X, 6 p.Article

Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliterTHOMPSON, Ian M; PAULER, Donna K; CROWLEY, John J et al.The New England journal of medicine. 2004, Vol 350, Num 22, pp 2239-2246, issn 0028-4793, 8 p.Article